All the drugs on the government's HIV/AIDS and tuberculosis control programs are likely to be added to the list of drugs subject to price caps.

About 12% of the medicines sold nationwide are currently under price caps, including 348 drugs classified as essential medicines. Though the companies are allowed to hike their prices by up to 10% a year, the government regulates the prices of all other medicines.
DG Shah, Secretary general, Indian Pharmaceutical Alliance (IPA) said, “It is a part of the policy. Pharmaceutical companies don't get a chance to hike prices (more than once) a year. This price hike is linked to inflation.”
All the drugs on the government's HIV/AIDS and tuberculosis control programs are likely to be added to the list of drugs subject to price caps.
Both local and foreign drug makers in India oppose the restrictions on price caps though the government earlier allowed pharmaceutical companies to hike rates of 509 essential medicines used for diabetes, hepatitis and cancer by 3.84%.
Source-Medindia
MEDINDIA









